ChengDa Pharmaceuticals Co., Ltd. (SHE:301201)
China · Delayed Price · Currency is CNY 23.26
-0.90 (-3.73%)
At close: Nov 13, 2026
ChengDa Pharmaceuticals Market Cap
ChengDa Pharmaceuticals has a market cap or net worth of 3.52 billion as of November 13, 2026. It is the 13,767th most valuable company in the world and the 3,638th biggest in China. Its market cap has decreased by 35.21% in one year.
Market Cap
3.52B
Enterprise Value
2.65B
Revenue
476.96M
Global Rank
Country Rank
#3,638 China
PE Ratio
n/a
ChartMarket Cap Chart
Since January 20, 2022, ChengDa Pharmaceuticals's market cap has decreased from 12.43B to 3.52B, a decrease of -71.66%. That is a compound annual growth rate of -23.03%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2026 | 3.52B | -42.85% |
| Dec 31, 2025 | 6.16B | 101.68% |
| Dec 31, 2024 | 3.06B | -22.31% |
| Dec 29, 2023 | 3.93B | -19.91% |
| Dec 30, 2022 | 4.91B | -60.48% |
| Jan 20, 2022 | 12.43B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| LanZhou Foci Pharmaceutical | 3.85B |
| Nanjing Well Pharmaceutical Group | 3.82B |
| Beijing Science Sun Pharmaceutical | 3.76B |
| Jiangsu Lianhuan Pharmaceutical | 3.71B |
| Shanghai Jiaoda Onlly Co.,Ltd | 3.65B |
| Shanghai Xiao Fang Pharmaceutical | 3.65B |
| Sinotherapeutics | 3.62B |
| Tibet Weixinkang Medicine | 3.57B |